Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Ebola 'international health emergency', Red Cross to save winter crisis and the cost of the 'dementia timebomb'

A round-up of the morning’s health news headlines on Friday 8 August.

The BBC leads on news the outbreak of Ebola in West Africa has been declared an international health emergency by the World Health Organisation.

So far 930 people have died from the virus and WHO officials say a coordinated international response is vital to stop its spread.

However, they said there would be no need for a general ban on international travel or trade.

Keiji Fukuda, the WHO’s head of health security, said with the right measures Ebola’s spread could be stopped.

‘This is not a mysterious disease. This is an infectious disease that can be contained,’ he said. ‘It is not a virus that is spread through the air.’

Elsewhere, The Telegraph reports that the Red Cross has been brought in to prevent a winter health crisis in the NHS, as waiting lists reach an all-time high.

Apparently NHS England is giving £2 million to groups, including Age UK, British Red Cross and Royal Voluntary Service to run schemes to help keep elderly people out of hospitals.

And the ‘dementia timebomb’ is going to cost British businesses £3 billion by 2030 according to a Government report, says the Independent.

The analysis compiled by experts at the Centre for Economic and Business Research for Public Health England and the Alzheimer’s Society says the estimated doubling of cases of dementia - to around 1.1 million - by then will drastically cut the over 65s workforce as well as driving people out of work to care for elderly relatives.

Readers' comments (1)

  • Worth looking at a recent edition of the New Scientist which has reported a trial of Etanercept for dementia. Weekly dose costing £89 for 8.2 million dementia suffers (Dementia UK) - you do the maths as our American cousins would say.
    PS - thats about £3.8 billion per year.

    Unsuitable or offensive? Report this comment

Have your say